Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs

Cancer Letters

Volumn 337, Issue 2, 2013, Pages 193-199

  Canitano, Andrea ^a   Venturi, Giulietta ^a   Borghi, Martina ^a   Ammendolia, Maria Grazia ^a   Fais, Stefano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

EBV; Exosomes; Latent infection; MiRNA; MRNA

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 2; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; MICRORNA BART1; MICRORNA BART2; MICRORNA BART3; MICRORNA BHRF1 3; NUCLEIC ACID; UNCLASSIFIED DRUG; VIRUS MESSENGER RNA; VIRUS RNA;

ARTICLE; CARCINOMA CELL; EBNA1 GENE; EBNA2 GENE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EXOSOME; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC CODE; IN VITRO STUDY; LMP1 GENE; LMP2 GENE; LMP2A GENE; LYMPHOBLASTOID CELL LINE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VIRUS GENE;

EBV; EPSTEIN-BARR VIRUS; EXOSOMES; LATENT INFECTION; LATENT MEMBRANE PROTEIN; LCL; LMP; LYMPHOBLASTOID CELL LINE; MESSANGER RNA; MICRO RNA; MIRNA; MRNA; QPCR; REAL-TIME PCR; REVERSE TRANSCRIPTION; RT;

CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; EXOSOMES; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPRECIPITATION; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 84880514548     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.05.012     Document Type: Article

References (36)

1. Meckes D.G., Raab-Traub N. Microvesicles and viral infection. J. Virol. 2011, 85:12844-12854.
2. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 2006, 2006(118):3030-3044.
3. Young L.S., Rickinson A.B. Epstein-Barr virus: 40years on. Nat. Rev. Cancer 2004, 4:757-768.
4. Thorley-Lawson D.A. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 2001, 2001(1):75-82.
5. Küppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 2003, 3:801-812.
6. Kaye K.M., Izumi K.M., Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 1993, 90:9150-9154.
7. Morris M.A., Dawson C.W., Young L.S. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol. 2009, 5:811-825.
8. Uchida J., Yasui T., Takaoka-Shichijo Y., Muraoka M., Kulwichit W., Raab-Traub N., Kikutani H. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 1999, 286:300-303.
9. E. Kieff, A.B. Rickinson, Epstein-Barr virus and its replication, in: Lippincott Williams, Wilkins (Eds.), Fields Virology, Philadelphia, 2001, pp. 2575-2627.
10. Caldwell R.G., Wilson J.B., Anderson S.J., Longnecker R. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 1998, 9:405-411.
11. Scholle F., Bendt K.M., Raab-Traub N. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 2000, 74:10681-10689.
12. Pfeffer S., Zavolan M., Grässer F.A., Chien M., Russo J.J., Ju J., John B, Enright A.J., Marks D., Sander C., Tuschl T. Identification of virus-encoded microRNAs. Science 2004, 304:734-736.
13. Cosmopoulos K., Pegtel M., Hawkins J., Moffett H., Novina C., Middeldorp J., Thorley-Lawson D.A. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J. Virol. 2009, 83:2357-2367.
14. Cai X., Schäfer A., Lu S., Bilello J.P., Desrosiers R.C., Edwards R., Raab-Traub N., Cullen B.R. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006, 2:e23.
15. Xia T., O'Hara A., Araujo I., Barreto J., Carvalho E., Sapucaia J.B., Ramos C., Luz E., Pedroso C., Manrique M., Toomey N.L., Brites C., Dittmer D.P., Harrington W.J. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 2008, 68:1436-1442.
16. Pratt Z.L., Kuzembayeva M., Sengupta S., Sugden B. The microRNAs of Epstein-Barr virus are expressed at dramatically differing levels among cell lines. Virology 2009, 386:387-397.
17. Lo A.K., Dawson C.W., Jin D.Y., Lo K.W. The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J. Pathol. 2012, 227:392-403.
18. Riley K.J., Rabinowitz G.S., Yario T.A., Luna J.M., Darnell R.B., Steitz J.A. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 2012, 31:2207-2221.
19. Dukers D.F., Meij P., Vervoort M.B., Vos W., Scheper R.J., Meijer C.J., Bloemena E., Middeldorp J.M. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J. Immunol. 2000, 165:663-670.
20. Flanagan J., Middeldorp J., Sculley T. Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J. Gen. Virol. 2003, 84:1871-1879.
21. Vazirabadi G., Geiger T.R., Coffin W.F., Martin J.M. Epstein-Barr virus latent membrane protein-1 (LMP-1) and lytic LMP-1 localization in plasma membrane-derived extracellular vesicles and intracellular virions. J. Gen. Virol. 2003, 84:1997-2008.
22. Keryer-Bibens C., Pioche-Durieu C., Villemant C., Souquère S., Nishi N., Hirashima M., Middeldorp J., Busson P. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 2006, 6:283.
23. Ceccarelli S., Visco V., Raffa S., Wakisaka N., Pagano J.S., Torrisi M.R. Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes. Int. J. Cancer 2007, 121:1494-1506.
24. Houali K., Wang X., Shimizu Y., Djennaoui D., Nicholls J., Fiorini S., Bouguermouh A., Ooka T. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 2007, 13:4993-5000.
25. Meckes D.G., Shair K.H., Marquitz A.R., Kung C.P., Edwards R.H., Raab-Traub N. Human tumour virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. USA 2010, 107:20370-20375.
26. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E.S., Lindenberg J.L., de Gruijl T.D., Würdinger T., Middeldorp J.M. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. USA 2010, 107:6328-6333.
27. Gourzones C., Gelin A., Bombik I., Klibi J., Vérillaud B., Guigay J., Lang P., Témam S., Schneider V., Amiel C., Baconnais S., Jimenez A.S., Busson P. Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol. J. 2010, 7:271.
28. Ikeda M., Longnecker R. Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability. Virology 2007, 360:461-468.
29. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell. Biol. 2007, 9:654-659.
30. Skog J., Würdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., Curry W.T., Carter B.S., Krichevsky A.M., Breakefield X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell. Biol. 2008, 10:1470-1476.
31. Kavathas P., Bach F.H., DeMars R. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 1980, 77:4251-4255.
32. Logozzi M., De Milito A., Lugini L., Borghi M., Calabrò L., Spada M., Perdicchio M., Marino M.L., Federici C., Iessi E., Brambilla D., Venturi G., et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 2009, 4:e5219.
33. Parolini I., Federici C., Raggi C., Lugini L., Palleschi S., De Milito A., Coscia C., Iessi E., Logozzi M., Molinari A., Colone M., Tatti M., et al. Microenvironmental pH is a key factor for exosome traffic in tumour cells. J. Biol. Chem. 2009, 284:34211-34222.
34. Barth S., Meister G., Grässer F.A. EBV-encoded miRNAs. Biochim. Biophys. Acta. 2011, 1809:631-640.
35. Kubota N., Wada K., Ito Y., Shimoyama Y., Nakamura S., Nishiyama Y., Kimura H. One-step multiplex real-time PCR assay to analyze the latency patterns of Epstein-Barr virus infection. J. Virol. Methods 2008, 147:26-36.
36. Bell A.I., Groves K., Kelly G.L., Croom-Carter D., Hui E., Chan A.T., Rickinson A.B. Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J. Gen. Virol. 2006, 87:2885-2890.